Intensity Therapeutics | 4:持股變動聲明-高管 Talamo Joseph
Intensity Therapeutics | 4:持股變動聲明-高管 Wesolowski John M
Intensity Therapeutics | SC 13G:超過5%持股股東披露文件-LFP Management, LLC(5.4%)
Intensity Therapeutics | 4:持股變動聲明-高管 Wesolowski John M
Intensity Therapeutics | 4:持股變動聲明-董事 DUBIN THOMAS I H
Intensity Therapeutics | 3:首次持股聲明-董事 DUBIN THOMAS I H
Intensity Therapeutics | 4:持股變動聲明-高管 Wesolowski John M
Intensity Therapeutics | 4:持股變動聲明-董事 Leahy Emer
Intensity Therapeutics | 4:持股變動聲明-董事 GOLDBERG MARK A
Intensity Therapeutics | 4:持股變動聲明-董事 Donovan Daniel
Intensity Therapeutics | 4:持股變動聲明-高管 BENDER LEWIS H
Intensity Therapeutics | SC 13G:超過5%持股股東披露文件-Lewis H. Bender(16.1%)
Intensity Therapeutics | 4:持股變動聲明-首席財務官 Talamo Joseph
Intensity Therapeutics | 3:首次持股聲明-首席財務官 Talamo Joseph
Intensity Therapeutics | 4:持股變動聲明-高管 Wesolowski John M
Intensity Therapeutics | 3:首次持股聲明-高管 Wesolowski John M
Intensity Therapeutics | 3:首次持股聲明-高管 BENDER LEWIS H
Intensity Therapeutics | 3:首次持股聲明-董事 GOLDBERG MARK A
Intensity Therapeutics | 3:首次持股聲明-董事 Leahy Emer
Intensity Therapeutics | 3:首次持股聲明-董事 Donovan Daniel
暫無數據
暫無數據